Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
43. (MXPA/a/2006/014057) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASE AND/OR SYMPTOMS IN ARTHRITIS

Application Number: PA/a/2006/014057 Application Date: 04.12.2006
Publication Number: PA/a/2006/014057 Publication Date: 08.06.2007
Publication Kind : A
Prior PCT appl.: Application Number:GB2005002233 ; Publication Number:05120478 Click to see the data
IPC:
A61K 31/047
A61K 31/352
A61P 19/02
A61P 29/00
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
045
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
047
having two or more hydroxy groups, e.g. sorbitol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
35
having six-membered rings with one oxygen as the only ring hetero atom
352
condensed with carbocyclic rings, e.g. cannabinols, methantheline
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19
Drugs for skeletal disorders
02
for joint disorders, e.g. arthritis, arthrosis
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29
Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
Applicants: GW PHARMA LIMITED
Inventors: GEOFFREY GUY
PHILIP ROBSON
Agents: JOSE F. HINOJOSA CUELLAR.*
Priority Data: 0412753.6 08.06.2004 GB
Title: (EN) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASE AND/OR SYMPTOMS IN ARTHRITIS
(ES) COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE ENFERMEDAD DE Y/O SINTOMAS DE ARTRITIS
Abstract:
(EN) The invention relates to the use of a combination of cannabinoids for the treatment of pain, inflammation and/or disease modification in arthritis. Preferably the cannabinoids are selected from cannabidiol (CBD) or cannabidivarin (CBDV) and delta-9-tetrahydrocannabinol (THC) or tetrahydrocannabinovarin (THCV). More preferably the cannabinoids are in a predefined ratio by weight of less than or equal to 19:1 of CBD or CBDV to THC or THCV.
(ES) La invención se refiere al uso de una combinación de cannabinoides para el tratamiento de dolor, inflamación y/o modificación de enfermedad en artritis. Preferiblemente, los cannabinoides se seleccionan de cannabidiol (CDB) o cannabidivarina (CBDV) y delta-9-tetrahidrocannabinol (THC) o tetrahidrocannabinovarina (THCV). Más preferiblemente, los cannabinoides están en una relación predefinida en peso de menos de o igual a 19:1 de CBD o CBDV a THC o THCV.